| Form type | Sec Links | Description | Filing date | Reporting date |
|---|---|---|---|---|
| 8-K | Report | Data | FORM 8-K | Feb 15, 2023 | Feb 15, 2023 |
| SC 13G | Report | Feb 14, 2023 | ||
| SC 13G/A | Report | SC 13G/A | Feb 14, 2023 | |
| SC 13G | Report | IBER 13G | Feb 8, 2023 | |
| SC 13G/A | Report | SCHEDULE 13G (AMENDMENT NO. 1) | Feb 8, 2023 | |
| SC 13G/A | Report | SC 13G/A | Feb 2, 2023 | |
| 10-Q | Report | Data | 10-Q | Nov 14, 2022 | Sep 30, 2022 |
| 10-Q | Report | Data | 10-Q | Aug 12, 2022 | Jun 30, 2022 |
| 10-Q | Report | Data | 10-Q | May 16, 2022 | Mar 31, 2022 |
| 10-K | Report | Data | 10-K | Mar 31, 2022 | Dec 31, 2021 |
| SC 13G/A | Report | IBERE PHARMACEUTICALS | Feb 14, 2022 | |
| SC 13G | Report | SC 13G | Feb 8, 2022 | |
| SC 13G | Report | SCHEDULE 13G | Jan 14, 2022 | |
| 10-Q | Report | Data | FORM 10-Q | Nov 12, 2021 | Sep 30, 2021 |
| SC 13G | Report | SCHEDULE 13G | Sep 27, 2021 | |
| 10-Q | Report | Data | FORM 10-Q | Aug 16, 2021 | Jun 30, 2021 |
| 10-Q/A | Report | Data | 10-Q/A | Aug 16, 2021 | Mar 31, 2021 |
| 8-K/A | Report | FORM 8-K/A | Aug 16, 2021 | Mar 2, 2021 |
| 8-K | Report | FORM 8-K | Aug 13, 2021 | Aug 10, 2021 |
| 8-K | Report | FORM 8-K | Aug 4, 2021 | Jul 29, 2021 |
| 10-Q | Report | Data | FORM 10-Q | Jul 16, 2021 | Mar 31, 2021 |
| 8-K | Report | FORM 8-K | May 28, 2021 | May 25, 2021 |
| SC 13G | Report | SC 13G | Mar 12, 2021 | |
| 8-K | Report | FORM 8-K | Mar 8, 2021 | Mar 2, 2021 |
| 8-K | Report | FORM 8-K | Mar 3, 2021 | Feb 25, 2021 |